-previr
A hepatitis C NS3/4A protease inhibitor.
- Drugs ending in -previr: 16
- Approved somewhere: 8
- With a US drug page: 3
Approved and clinical-stage drugs in ChEMBL whose names ending in -previr, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Boceprevir | Approved | NS3, NS4A | Hepatitis C virus serine protease, NS3/NS4A inhibitor |
| Simeprevir | Approved | NS3, NS4A | Hepatitis C virus serine protease, NS3/NS4A inhibitor |
| Telaprevir | Approved | NS3, NS4A | Hepatitis C virus serine protease, NS3/NS4A inhibitor |
| Asunaprevir | Approved | NS3, NS4A | Hepatitis C virus serine protease, NS3/NS4A inhibitor |
| Glecaprevir | Approved | NS3, NS4A | Hepatitis C virus serine protease, NS3/NS4A inhibitor |
| Grazoprevir anhydrous | Approved | NS3, NS4A | Hepatitis C virus serine protease, NS3/NS4A inhibitor |
| Paritaprevir | Approved | NS3, NS4A | Hepatitis C virus serine protease, NS3/NS4A inhibitor |
| Voxilaprevir | Approved | NS3, NS4A | Hepatitis C virus serine protease, NS3/NS4A inhibitor |
| Danoprevir | Phase 3 | NS3, NS4A | Hepatitis C virus serine protease, NS3/NS4A inhibitor |
| Faldaprevir | Phase 3 | NS3, NS4A | Hepatitis C virus serine protease, NS3/NS4A inhibitor |
| Furaprevir | Phase 3 | NS3, NS4A | Hepatitis C virus serine protease, NS3/NS4A inhibitor |
| Narlaprevir | Phase 3 | NS3, NS4A | Hepatitis C virus serine protease, NS3/NS4A inhibitor |
| Vaniprevir | Phase 3 | NS3, NS4A | Hepatitis C virus serine protease, NS3/NS4A inhibitor |
| Sovaprevir | Phase 2 | NS3, NS4A | Hepatitis C virus serine protease, NS3/NS4A inhibitor |
| Vedroprevir | Phase 2 | NS3, NS4A | Hepatitis C virus serine protease, NS3/NS4A inhibitor |
| Ciluprevir | — | NS3, NS4A | Hepatitis C virus serine protease, NS3/NS4A inhibitor |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO